.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fuji
Mallinckrodt
Cipla
Johnson and Johnson
UBS
US Army
Harvard Business School
Cerilliant
Accenture

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040195

« Back to Dashboard
NDA 040195 describes ACETAZOLAMIDE, which is a drug marketed by Zydus Pharms Usa Inc, Alra, Heritage Pharma, Novast Labs Ltd, Lannett, Mutual Pharm, Sun Pharm Inds, Vangard, Heritage Pharms Inc, Watson Labs, Ascot, Nostrum Labs Inc, Taro, Hospira, Sagent Agila, X Gen Pharms, West-ward Pharms Int, and Emcure Pharms Ltd, and is included in nineteen NDAs. It is available from sixteen suppliers. Additional details are available on the ACETAZOLAMIDE profile page.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for NDA: 040195

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 040195

Ingredient-typeSulfonamides
Mechanism of ActionCarbonic Anhydrase Inhibitors

Suppliers and Packaging for NDA: 040195

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL 040195 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-1511 0615-1511-39 30 TABLET in 1 BLISTER PACK (0615-1511-39)
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL 040195 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-4022 51672-4022-1 100 TABLET in 1 BOTTLE (51672-4022-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength125MG
Approval Date:May 28, 1997TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:May 28, 1997TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Chubb
Teva
AstraZeneca
Cerilliant
Chinese Patent Office
Express Scripts
US Department of Justice
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot